A vs TECH: fair value comparison
Agilent Technologies, Inc. and Bio-Techne Corporation · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, TECH currently sits closer to the top of our discount ranking. TECH carries the stronger quality grade.
| A | TECH | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $146.93 | $72.12 |
| 12-month range | $114.52–$150.10 | $50.79–$72.18 |
| Sector rank | #57 of 113 Healthcare | #52 of 113 Healthcare |
| Quality grade | B | A |
| Leverage | Moderate | Low |
| Margin trend | Stable | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Uptrend |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: A fair value analysis · TECH fair value analysis